4.1.4建议对CKD患者进行骨质疏松骨折风险预测。较为常用的预测方法是亚洲人骨质疏松自我筛查工具(osteoporosis self-screening tool, OSTA)和WHO骨折风险预测简易工具(WHO fracture riskassessment tool,FRAX)。(未分级) 4.2 骨质疏松的基础治疗 调整生活方式对骨质疏松的预防和治疗具有重要意义,主要措施包括:均衡膳食,合理...
目的探讨骨密度和骨代谢标志物联合骨折风险评估工具(fracture risk assessment tool,FRAX)评估甲状腺癌术后患者骨折风险.方法我院2018年6月至2020年12月期间,门诊和住... 吴倩,王亚楠,鹿峰,... - 《标记免疫分析与临床》 被引量: 0发表: 2022年 FRAX 探讨绝经后骨质疏松症中医证型与骨折风险的相关性研究 Obje...
“Three” Discoveries of Losartan A new chemical class: the biphenyl-tetrazoles An important new scientific tool to explore receptor subtypes and the pathobiology of angiotensin II An important new therapeutic agent – first antihypertensive to demonstrate “placebo-like” side effects AII Antagonist ...
Revisiting the dialysate sodium prescription as a tool for better blood pressure and interdialytic weight gain management in hemodialysis patients. Clin J Am Soc Nephrol. 2008;3:522–30. CAS PubMed Google Scholar Davenport A. Audit of the effect of dialysate sodium concentration on inter-...
More emphasis has been given to the quantitative rather than qualitative assessment of bone health, both in general population and CKD patients. Although bone mineral density (BMD) is a very useful clinical tool in assessing bone strength, it may underestimate the fracture risk in CKD pa...
Understanding symptoms in patients with advanced chronic kidney disease managed without dialysis: use of a short patient-completed assessment tool. Nephron Clin Pract. 2009;111(1):c74–80. Article Google Scholar Davison SN, Jhangri GS, Johnson JA. Cross-sectional validity of a modified Edmonton ...
Researchers at Boston’s Joslin Diabetes Center have developed a prognostic tool that predicts the risk of end-stage renal disease (ESRD) in patients with type 1 or type 2 diabetes. “Overall efficiency and ...Read more April 17, 2017April 17, 2017 ...
risk of CKD complications such as sodium and volume overload, hyperkalemia, hyperphosphatemia, or malnutrition, which affect the cardiovascular system, bones, and other organs [2]. Nutritional education is therefore recognized as an important tool in the treatment of patients with CKD, but is ...
Another limitation of our study is the cross-sectional design as this design does not allow for serial assessment of this marker as a measure of progressive deterioration of kidney function. Therefore, it is difficult to ascertain from this work if uTGF-β1Cr increase predates the occurrence of...
Accurate progression risk assessment may help optimize resource allocation and adapting care based on individual patients’ needs. This study validated the Prognostic Reasoning System for Chronic Kidney Disease Progression (PROGRES-CKD) in an Italian public hospital and compared its potential impact on ...